跳至主要内容
临床试验/NCT06082466
NCT06082466招募中不适用

FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial

Paracelsus Medical University2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2023年9月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
110
试验地点
2
主要终点
Incidence of primary patency of the venous bypass

研究概览

简要总结

The purpose of this clinical trial is to analyze patency after autologous infrainguinal bypass surgery in patients receiving a venous conduit versus a covered venous conduit.

详细描述

Patients presenting to Vascular Surgical Units are usually multimorbid with increased cardiopulmonary risk. Autologous venous bypass is indicated in certain situations despite the longer duration of surgery. Optimizing patency has been an important goal since many years. Reconstruction problems are often based on intimal hyperplasia, which can be reduced via covering of the harvested vein as seen in previous studies.

This clinical trial will be conducted at our Division of Vascular Surgery and Endovascular Surgery at the University Hospital of Salzburg. Patients will be randomized into one of the two treatment options, which are a plain venous conduit or a by mesh covered venous conduit. During this clinical trial, the first follow-up will take place after 6 weeks; this corresponds to the usual follow-up interval. Due to the trial, further follow-ups will take place for each of the patients after 3 months, 6 months, 12 months, 2 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age at least 18 years
  • Informed consent form with signature
  • Rutherford Category 3 (<200m) or chronic critical ischemia (Rutherford Category 4-6)
  • Assured inflow and recipient artery.

排除标准

  • Pregnant or breastfeeding women
  • Active infection or sepsis
  • Acute ischemia
  • Endovascular procedure in the region to be treated.
  • Vein with outer diameter <3.5 mm or >8 mm under pressure.
  • Spliced Veins.
  • Known allergy to the cobalt-chromium alloy (ASTM 1058) or its components (Cobalt-Chromium-Iron-Nickel-Molybdenum).
  • Vasculitis
  • Coagulopathy
  • Radiation therapy near the anastomosis

结局指标

主要结局

Incidence of primary patency of the venous bypass

时间窗: 2 years

The incidence of patency of the venous bypasses will be analysed and compared. This is defined as freedom from occlusion of the venous bypass.

次要结局

  • Incidence of limb salvage after procedure(2 years)
  • Incidence of procedure-related mortality(2 years)
  • Incidence of 30-day mortality(30 days)

研究者

发起方
Paracelsus Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Klaus Linni

Head of Division of Vascular and Endovascular Surgery, MD PD

Paracelsus Medical University

研究点 (2)

Loading locations...

相似试验